Appropriate assessment of body composition to identify haemodialysis patients at risk  by Castellano, Sandra et al.
n e f r o l o g i a. 2 0 1 6;3 6(3):268–274
Revista de la Sociedad Española de Nefrología
w w w.rev is tanef ro logia .com
Original article
Appropriate  assessment  of body composition  to identify
haemodialysis patients  at  risk
Sandra Castellanoa,∗, Inés Palomaresa, Ulrich Moisslb, Paul Chamneyb,
Diana  Carreteroa, Antonio Crespoa, Camilo Morentea, Laura Riberaa, Peter Wabelb,
Rosa  Ramosa, José Ignacio Merelloa
a Fresenius Medical Care, Tres Cantos (Madrid), Spain
b Fresenius Medical Care, Bad Homburg, Germany
a  r  t  i  c  l  e  i  n  f  o
Article history:
Received 14 March 2015
Accepted 13 January 2016







a  b  s  t  r  a  c  t
Introduction: Circumstances such as gender, age, diabetes mellitus (DM) and renal failure
impact on the body composition of patients. However, we use nutritional parameters such
as  lean and fat tissue with reference values from healthy subjects to assess the nutritional
status of haemodialysis (HD) patients.
Aims: To analyse body composition by bioimpedance spectroscopy (BIS) of 6395 HD patients
in  order to obtain reference values of lean tissue index (LTI) and fat tissue index (FTI) from
HD  patients; and to conﬁrm its validity by showing that those patients with LTI below the
10th  percentile calculated for their group have greatest risk of death.
Material and methods: We  used the BIS to determine the LTI and FTI in our cohort of HD
patients in Spain. We  calculated the 10th percentile and 90th percentile of LTI and FTI in
each age decile for patients grouped by gender and presence of DM. We  collected clinical,
laboratory and demographic parameters.
Results: The LTI/FTI 10 and 90 percentile values varied by group (age, gender and presence
of  DM) and, after adjusting for other risk factors such as ﬂuid overload, those patients with
LTI  lower than percentile 10 had a higher relative risk of death (OR 1.57) than those patients
with higher values.
Conclusions: Monitoring the LTI and FTI of patients on HD using suitable reference values
may  help to identify risk in this patient population.©  2016 Sociedad Espan˜ola de Nefrologı´a. Published by Elsevier Espan˜a, S.L.U. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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Índice de tejido magro
Sobrehidratación
r  e  s  u  m  e  n
Introducción: Circunstancias como el género, la edad, la presencia de diabetes mellitus (DM)
y  la insuﬁciencia renal tienen impacto sobre la composición corporal de los pacientes. Sin
embargo, a la hora de evaluar parámetros nutricionales como el tejido magro y graso de los
pacientes en hemodiálisis (HD) se emplean valores de referencia provenientes de población
sana.
Objetivos: Analizar la composición corporal mediante bioimpedancia espectroscópica (BIS)
de  6.395 pacientes en HD para obtener valores de referencia de índice de tejido magro (ITM)
y  de índice de tejido graso (ITG) procedentes de pacientes en HD y conﬁrmar su validez
al  demostrar que aquellos con un ITM por debajo del percentil 10 calculado para su grupo
tienen mayor riesgo de muerte.
Material y métodos: Usamos la BIS para determinar el ITM e ITG de nuestra cohorte de
pacientes en HD en Espan˜a. Calculamos el percentil 10 y el percentil 90 del ITM e ITG en
cada decil de edad de pacientes, agrupados según su género y presencia de DM. Recogemos
parámetros clínicos, analíticos y demográﬁcos.
Resultados: Objetivamos que los valores del percentil 10 y del 90 de ITM/ITG varían en función
del  grupo (edad, género y presencia de DM) y que, tras ajustar por otros factores de riesgo
como la sobrehidratación, los pacientes con ITM inferior al percentil 10 tienen mayor riesgo
relativo de muerte (OR 1,57) que aquellos con valores superiores.
Conclusiones: Monitorizar el ITM e ITG de los pacientes en HD con adecuados valores de
referencia puede ser útil para identiﬁcar situaciones de riesgo en los pacientes en HD.
©  2016 Sociedad Espan˜ola de Nefrologı´a. Publicado por Elsevier Espan˜a, S.L.U. Este es un


























ircumstances such as age,1–5 gender,5,6 diabetes mellitus
DM)1,5,7 or kidney failure8,9 have an impact on patients’ body
omposition. In fact, older patients generally have less lean
issue than younger patients, women have less lean tissue
han men, patients with DM usually have more  fat tissue than
on-diabetics, and patients on dialysis have less lean and fatty
issue than healthy people, this is likely the result of being in
 hypercatabolic state10 with insufﬁcient intake/absorption of
utrients.11–13
Therefore, given that a higher presence of lean tissues
as been correlated with better survival14,15 in patients on
aemodialysis (HD), reference values16 adapted to the HD
opulation should be available. These values must take into
ccount characteristics such as age, gender, or DM, in order to
et an adequate assessment of body composition parameters
uch as the lean tissue index (LTI) or the fat tissue index (FTI).
The use of body composition monitors has been extended
n the HD units because of its easy of use and because they
ave been validated in the healthy and HD populations.16–20
ody Composition Monitor (BCM) (Fresenius Medical Care,
ad Homburg, Germany) based on bioimpedance spectroscopy
BIS) will be used in the present study.
The aim is, ﬁrstly, to describe the body composition of
395 patients and to calculate the 10th and 90th percentiles
f LTI/FTI in 4 groups of patient (diabetic men, non-diabetic
en, diabetic women, non-diabetic women) relative to age, so
ercentiles will serve as a reference to assess patient’s leanby-nc-nd/4.0/).
and fat tissue content. Secondly, to evaluate the mortality of
the population and determine if having a LTI below the 10th
percentile in their corresponding group carries a higher risk




This is a retrospective, observational, cohort study on body
composition in 6395 patients (incident and prevalent) in HD
treated in 57 FMC HD units in Spain. The study period ran
from January 2012 to December 2014.
The inclusion criteria: patients treated in Fresenius Med-
ical Care (FMC) clinics in Spain during the inclusion period
(incident and prevalent patients) with at least one BCM
measurement. The exclusion criteria are: patients with pace-
makers and amputees.
All the patients are registered in the EuCliD® database (Fre-
senius Medical Care’s European Clinical Database), described
in previous works,21,22 and all signed the informed consent
form.
DesignThe patients are grouped based on their gender and the pres-
ence of DM and stratiﬁed by age deciles. The result from the
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vascular access, overhydration (ROH greater than 15%), and
albumin.
Table 1 – Baseline characteristics of 6395 haemodialysis
patients.
Parameter Mean (SD)
Age (years) 67.6 (14.7)
Gender (% women) 37.3
Cause of kidney disease (undetermined) 31.5
Diabetes mellitus (%) 28.5
Cardiovascular disease (%) 30.3
Vascular access (% catheter) 31.8
Vintage (months) 36.7 (43.3)
ROH (%) 10.9 (9.7)
SBP/month (mmHg) 134.6 (21.1)
DBP/month (mmHg) 66.5 (12.0)
LTI (kg/m2) 11.5 (2.9)
FTI (kg/m2) 14.8 (6.5)
Adjusted Charlson I. 5.5 (1.9)
Dialysis dose (std Kt/V) 1.7 (0.3)
Haemoglobin (g/dl) 11.3 (1.5)
ERI (IU/kg/week/g/dl) 9.3 (8.9)
logCRP 1.6 (1.5)
Albumin (g/dl) 3.8 (0.4)
Effective time per session (minutes) 236.8 (19.4)270  n e f r o l o g i a. 2
ﬁrst BCM measurement is collected from the patients, and the
10th and 90th percentiles of LTI and FTI are calculated in each
age decile in the 4 groups. All deaths and their causes are
recorded, and a logistic regression was performed to deter-
mine the odds ratio (OR) of death from variables including the
presence of a “LTI below the 10th percentile”.
Assessment  of  body  composition  by  body  composition
monitor
Measurements with the BCM were performed by trained nurs-
ing staff before the HD session with the patient seated,
following a common electrode placement protocol. The ﬁrst
BCM measurement was selected in all patients.
The following BCM data were recorded: absolute overhy-
dration (OH) in litres as pre-HD weight minus  normohydration
weight calculated by BCM, relative overhydration (ROH, %) cal-
culated as the quotient of OH divided by extracellular water in
litres, LTI (kg/m2) and FTI (kg/m2) or lean tissue and fat tissue
adjusted by height.
Patients’ systolic and diastolic blood pressure obtained in
supine position before HD were collected and the mean values
of blood pressure (systolic and diastolic) during that month
period were calculated.
Demographic,  blood  test,  and  therapeutic  and
haemodialysis  session-related  parameters
Age, vintage, age-adjusted Charlson index, presence of DM,
and causes of kidney disease and death were collected.
The blood test data were collected prior to the mid  week
HD session. The parameters included in the analysis were:
haemoglobin, albumin (83.9% through the bromocresol green
method and 16.1% through the bromocresol purple method),
and C-reactive protein.
With regard to HD, we collected: vascular access, mean
effective time per HD session (T); Kt/V by ionic dialysance; the
number of blood pressure drugs per month, and the calculated
erythropoietin resistance index.
Statistical  analysis
The statistical analysis was performed using the SPSS sta-
tistical package (IBM SPSS, Inc., Chicago, IL, USA), version
19. The Kolmogorov–Smirnov test was used to identify the
non-parametric variables and these were log-transformed (e.g.
CRP). The qualitative variables were expressed as percentages
and the quantitative variables as mean ± standard deviation.
Student’s t-test, Mann–Whitney test, or ANOVA were used
to compare quantitative variables, according to their nor-
mal  or non-parametric distribution. The Chi-squared test was
used for qualitative variables. A p-value <0.05 was considered
statistically signiﬁcant. Multivariate logistic regression was
performed as an analysis of survival to detect the OR (relative
risk of death) of variables such as “LTI below the 10th per-
centile” with a 95% conﬁdence interval. This analysis included
confounding factors such as age, gender, vintage, vascular
access (catheter), age-adjusted Charlson index, overhydration
(ROH > 15%), and plasma albumin.;3 6(3):268–274
Results
The baseline characteristics of the cohort are shown in Table 1.
The causes of kidney disease were: undetermined (31.5%),
diabetic nephropathy (21.8%), glomerulonephritis (15.3%),
nephroangiosclerosis (12.2%), tubulointerstitial nephropathy
(9.5%), polycystic kidney disease (7.2%), and other (2.6%). As
for vascular access: 31.8% of patients received dialysis through
a catheter and 68.2% through an autologous or heterologous
arteriovenous ﬁstula.
Patients were grouped by gender and presence of DM.  The
25th, 50th, and 75th percentiles of LTI and FTI were calculated
for each of the four groups (Fig. 1).
The 10th and 90th percentiles were also calculated for each
age decil in the four patient groups. Fig. 2 shows the patient
distribution based on their LTI: those with an LTI below the
10th percentile or over the 90th percentile (black points) and
those with an LTI between the 10th and 90th percentiles (grey
points).
A total of 707 patients died during follow-up (11.1%), the
majority of them from a cardiovascular cause (41.6%). Of the
surviving patients, 79.1% continued HD in FMC  centres, 10.8%
transferred to non-FMC centres, 7.8% received transplants,
1.9% stopped renal replacement therapy, and 0.4% recovered
kidney function.
The result from the survival analysis using multivariate
logistic regression is shown in Table 2. It includes the fac-
tor “LTI below the 10th percentile of their group and age”
and others such as: age, gender, vintage, Charlson index,Adjusted Charlson index: age-adjusted Charlson index; CRP: C-
reaction protein; DBP: diastolic blood pressure; ERI: erythropoietin
resistance index; FTI: fat tissue index; LTI: lean tissue index; ROH:
relative overhydration; SBP: systolic blood pressure.
















MD = diabetic men; MnD = non-diabetic men;
WD = diabetic women; WnD = non-diabetic women
25th, 50th, and 75th FTI percentiles for the indicated groups
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Table 2 – Logistic regression with odds ratio and
conﬁdence interval.
Logistic regression Univariate Multivariate
LTI below p10 1.860 (1.494–2.314)* 1.576 (1.127–2.204)*
ROH > 15% 1.920 (1.638–2.250)* 1.625 (1.262–2.091)*
Age (by year) 1.048 (1.041–1.056)* 1.029 (1.015–1.044)*
Gender (male) 1.083 (0.920–1.274) 1.154 (0.894–1.490)
Vintage (months) 1.006 (1.005–1.008)* 1.009 (1.006–1.012)*
Vascular ac. (catheter) 1.755 (1.464–2.104)* 1.627 (1.260–2.100)*
Adjusted Charlson I 1.325 (1.270–1.382)* 1.140 (1.043–1.247)*
Albumin (g/dl) 0.417 (0.337–0.515)* 0.612 (0.457–0.819)*
Adjusted Charlson index: age adjusted Charlson index; HD:
haemodialysis; LTI: lean tissue index; ROH > 15%: relative overhy-
dration greater than 15%; Vascular ac.: vascular access.ndex (FTI) and lean tissue index (LTI) for the 4 groups.
iscussion
he work provides LTI and FTI reference values (10th and
0th percentiles) adjusted for age, gender, and DM for the
D population, coming from the HD population. The descrip-
ive analysis conﬁrms the effect of some circumstances on
he body composition of HD patients, such as age,1–4 gender6
nd DM1,7 and, therefore, the need to assess patients’ body
omposition taking these circumstances into account.
The sample size, representing a substantial proportion of
D patients in Spain, is one of the work’s strengths. This
nabled us to obtain LTI and FTI reference ranges for HD
atients coming from subjects with their same characteris-
ics. To our knowledge to date, Until now, the reference values
or the body composition parameters obtained using BIS came
rom healthy patients.6Furthermore, it was observed that the presence of less lean
issue, deﬁned a “LTI below the 10th percentile of their group”
arries a higher risk of death in HD (OR 1.57), which also∗ p < 0.05.
demonstrates that the reference values provided by the work
are valid, illustrative, and adequate.
The study shows that the association between low LTI and
mortality remains statistically signiﬁcant, even after adjus-
ting for other risk factors such as time in HD,23 vascular
access,24 Charlson index,1,6,7 relative overhydration greater
than 15%7,25–29 and albumin.23,30–33
Previous studies have examined the correlation between
low lean tissue (expressed as LTI below the 10th percentile
in the present study) and worse survival in HD34. Among the
possible causes we  note that (1) a lower lean mass may be a
sign of malnutrition35,36 or a sign of inﬂammation;36 (2) that
there may be uraemic toxin deposits in lean tissue, and there-
fore, lesser lean tissue may indicate a higher concentration of
uraemic toxins in blood;36,37 (3) that the increase in lean tis-
sue (and muscle mass) is associated with physical activity and
this improves vascular rigidity and insulin resistance;1,36 and,
lastly, (4) the known correlation between muscle mass and
mortality caused by infections in HD patients, since chronic
kidney disease patients have an acquired immunodeﬁciency
that may become exacerbated in patients with little muscle
mass by sharing risk factors such as hypoalbuminemia and
protein-energy wasting (PEW).2
According to the possible explanations, we  must add that
patients with LTI below the 10th percentile present higher
levels of CRP, but their dialysis doses are those recom-
mended by the guidelines.38–41 Thus, the body composition
of HD patients, and especially those with LTI below the 10th
percentile, could reﬂect an underlying disease (inﬂamma-
tory processes or malnutrition) or could perhaps predispose
patients to risky situations, such as infections.
The results of the study suggest that the physicians should
establish some diagnostic and therapeutic measures in HD
patients with low LTI.42 Firstly, at attempt to identify the rea-
son of low lean tissue and treat the underlying cause; secondly,
to determine if nutritional intervention such as oral or intra-
venous supplement may be useful in this type of patient; and
thirdly, to improve the dialysis dose if the cause is attributed
to underdialysis.
This study shows the 10th and 90th percentile values
adjusted by age, gender, and DM in a signiﬁcant number of
HD patients in Spain. These LTI/FTI values may be used by
physicians as reference values to assess the nutritional status
 0 1 6272  n e f r o l o g i a. 2
of HD patients. In fact, using these values as a guide, it was
shown that the presence of a “LTI below the 10th percentile”
for their group is correlated with a higher risk of death, even
after adjusting for other factors such as overhydration.
One of the limitations of this study is that the patients’
race was not taken into account since the vast majority of
patients were Caucasioan1; but reference values are needed
for other races. Other limitations are that neither the inter-
ventions (such as nutritional support or physical activity) nor
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Fig. 2 – Patient distribution based on lean tissue index (LTI). Blac
above the 90th percentile, grey points are those with an LTI betw;3 6(3):268–274
effects on body composition or on morbidity-mortality of the
patients were recorded. This could be taken into account in
future works. Similarly, as more  patients are incorporated to
total sample, also vintage can be considered a grouping factor.
In conclusion, new diagnostic tools such as BCM allow us a
simultaneous assessment of hydration and nutrition situation
of HD patients. Monitoring the body composition of patients
and its assessing using adequate reference values may be
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Now it remains to be shown in prospective studies if nutri-
ional intervention with an increase in lean tissue may result
n improved survival.
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